Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120601
Status:
UNKNOWN
Last Update Posted:
2005-07-18
First Post:
2005-07-11
Brief Title:
Trial for the Treatment of Alcohol Dependence
Sponsor:
University of Sydney
Organization:
University of Sydney
Study Overview
Official Title:
The Role of Pharmacotherapy in Prevention of Relapse in Alcohol Dependence
Status:
UNKNOWN
Status Verified Date:
2005-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the effectiveness of two anti-craving medications naltrexone versus acamprosate in the treatment of alcohol dependence
Detailed Description:
The physical psychological and social consequences of alcohol abuse remain a critical health problem Every year in Australia excessive consumption is responsible for 3000 - 6000 deaths and costs the community 6 billion Approximately 15 of Australians abuse alcohol and 5 of men and 3 of women are alcohol dependent addicted to alcohol Better treatment for alcohol dependence is urgently needed Treatment for alcohol dependence remains unsatisfactory Most treatments lead to abstinence in only 1 out of 3 cases and approximately 50 of these will relapse within 3 months of completing treatment Two drugs naltrexone and acamprosate appear to interfere with the effects of alcohol on the brain that promote addiction There is evidence that both drugs are beneficial in the treatment of alcohol dependence and both are now available in Australia At present no data have been reported comparing the effectiveness of these two drugs The proposed project will compare naltrexone and acamprosate in a large carefully performed study The study will help determine which subjects are likely to benefit from one or the other of these agents
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 211177 | None | None | None |